Skip to content
Reflections of yellow marbles on metal holders
Reflections of yellow marbles on metal holders

Food and Cosmetics

Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.

Our Life Sciences team has experience of advising many cosmetic and food companies, including Cargill, LVMH Perfumes and Cosmetics, Primark, United Biscuits, McDonalds, Heineken, Kraft Foods Inc, Nestlé, British Sugar and Heinz, among others. We have advised on issues including health claims, composition and labelling requirements, and various marketing issues. Our lawyers know the issues the industry faces and understand how to deal with them. The team has the added benefit of being fully integrated into Allen & Overy’s broader Life Sciences team and benefits from insights and expertise from our dedicated Life Sciences regulatory group.

News and insights

blurred lights in a tunnel

Publications: 02 February 2023

Podcast: Sanctions outlook 2023

Sanctions began dominating the headlines again in 2022. Largely, reports focused on the ongoing sanctions targeting Russia. As we look ahead to 2023, Russia remains a target. Other countries (such as…

Read more
Lab worker using syringe

Blog Post: 01 February 2023

Clinical Trial Regulation: Balancing Transparency Requirements and Protection of CCI – new Q&A published

The Clinical Trial Regulation (EU) No 536/2014 (CTR) became fully applicable yesterday (31 January), following the end of the transition period. Therefore, the use of the Clinical Trial Information…

Read more
Cell with needle

Blog Post: 02 December 2022

Is a local GMO ban compliant with EU law?

On 7 July 2022, the Court of Justice of the European Union (the CJEU) issued a preliminary ruling on a regional law banning a Genetically Modified Organism (GMO) previously authorised in Europe. 

Read more
Green liquid being dropped into test tube

Blog Post: 23 November 2021

The Belgian Joint Commission’s Chamber for Products for Human Use no longer considers oral nicotine pouches to qualify as medicinal products

In a new decision dated 24 September 2021, the Belgian Joint Commission's Chamber for Products for Human Use reversed its previous decision dated 27 November 2020, and now considers that oral nicotine…

Read more

Download our sector brochure

Life sciences A&O red molecules

Our Life Sciences and Healthcare sector focus 2022

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.